Rocket Pharmaceuticals, Inc. - RCKT

SEC FilingsOur RCKT Tweets

About Gravity Analytica

Recent News

  • 09.09.2025 - Morgan Stanley 23rd Annual Global Healthcare Conference
  • 09.03.2025 - 2025 Cantor Fitzgerald Global Healthcare Conference
  • 08.28.2025 - Rocket Pharmaceuticals to Participate in Upcoming Investor Conferences
  • 08.20.2025 - Rocket Pharmaceuticals Announces FDA Has Lifted the Clinical Hold on the Pivotal Phase 2 Trial of RP-A501 for the Treatment of Danon Disease

Recent Filings

  • 08.27.2025 - 4 Statement of changes in beneficial ownership of securities
  • 08.25.2025 - 8-K Current report
  • 08.20.2025 - 4 Statement of changes in beneficial ownership of securities
  • 08.20.2025 - 4 Statement of changes in beneficial ownership of securities
  • 08.20.2025 - 8-K Current report
  • 08.20.2025 - 4 Statement of changes in beneficial ownership of securities
  • 08.20.2025 - 4 Statement of changes in beneficial ownership of securities
  • 08.20.2025 - EX-99.1 EX-99.1
  • 08.19.2025 - 144 Report of proposed sale of securities
  • 08.19.2025 - 144 Report of proposed sale of securities